Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Documenti analoghi

• Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
  di: Shiwen, X, et al.
  Pubblicazione: (2006)
• Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
  di: S. Soldano, et al.
  Pubblicazione: (2011-01-01)
• Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
  di: Alix Naert, et al.
  Pubblicazione: (2013-01-01)
• CTGF overexpressing mice: a model for human scleroderma
  di: Sonnylal, S, et al.
  Pubblicazione: (2006)
• Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
  di: Emma Di Poi, et al.
  Pubblicazione: (2023-11-01)